相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Management of venous thromboembolism in cancer patients: ESMO Clinical Recommendations
M. Mandala et al.
ANNALS OF ONCOLOGY (2009)
Thromboembolism in Patients With Advanced Gastroesophageal Cancer Treated With Anthracycline, Platinum, and Fluoropyrimidine Combination Chemotherapy: A Report From the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group
Naureen Starling et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival
Nicole M. Kuderer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Genetic Link Between Cancer and Thrombosis
Carla Boccaccio et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Role of Tissue Factor in Cancer
Raj S. Kasthuri et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Thrombotic Events in Patients With Cancer Receiving Antiangiogenesis Agents
Maurizio Zangari et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Patterns of Use and Risks Associated With Erythropoiesis-Stimulating Agents Among Medicare Patients With Cancer
Dawn L. Hershman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Expression in Canine and Feline Meningioma
M. T. Mandara et al.
VETERINARY PATHOLOGY (2009)
Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With Cancer
Alok A. Khorana et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Vascular Access in Oncology Patients
Maurizio Gallieni et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Thromboprophylaxis for patients with cancer and central venous catheters
Elie A. Akl et al.
CANCER (2008)
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients
Melina Verso et al.
INTERNAL AND EMERGENCY MEDICINE (2008)
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients A Meta-analysis
Shobha Rani Nalluri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
Alexander T. Cohen et al.
LANCET (2008)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
Norman Williams
LANCET ONCOLOGY (2008)
Cancer and thrombosis: an increasingly important association
Wolfgang Korte
SUPPORTIVE CARE IN CANCER (2008)
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Alok A. Khorana et al.
CANCER (2007)
The role of oral anticoagulants in tumor biology
Ilene C. Weitz et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
The role of tissue factor pathway inhibitor in tumor growth and metastasis
Ali Amirkhosravi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Heparin in tumor progression and metastatic dissemination
Anna Falanga et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
Frank A. Scappaticci et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database
Helen E. Seaman et al.
BJU INTERNATIONAL (2007)
Venous thromboembolism in ovarian cancer
Anne O. Rodriguez et al.
GYNECOLOGIC ONCOLOGY (2007)
Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: Results from the Patient Safety in Surgery Study
Selwyn O. Rogers et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer:: Update of study BIG 1-98
Alan S. Coates et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients
Julia Bohlius et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer
AYY Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Incidence of venous thrombosis in a large cohort of 66 329 cancer patients:: results of a record linkage study
JW Blom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Venous thromboembolism in patients with colorectal cancer: Incidence and effect on survival
A Alcalay et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Risk factors for venous thromboembolic events in cancer patients
K Kröger et al.
ANNALS OF ONCOLOGY (2006)
Thromboembolism in hospitalized neutropenic cancer patients
AA Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery - The @RISTOS project
G Agnelli et al.
ANNALS OF SURGERY (2006)
Thromboembolic events in gastric cancer: High incidence in patients receiving irinotecan- and bevacizumab-based therapy
MA Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women
WJ Gradishar
ONCOLOGY (2005)
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
RC Coombes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry
M Monreal et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
DH Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Risk factors for catheter-related thrombosis in cancer patients
MET Tesselaar et al.
EUROPEAN JOURNAL OF CANCER (2004)
Thrombotic complications of central venous catheters in cancer patients
DJ Kuter
ONCOLOGIST (2004)
Meta-analysis of vascular and neoplastic events associated with tamoxifen
RS Braithwaite et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2003)
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients
M Verso et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
F Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy
M Zangari et al.
BLOOD (2002)
Prognosis of cancers associated with venous thromboembolism.
HT Sorensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study
JA Heit et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
